Tadalafil Tablet, Film Coated
Product Images NDC 50090-7315

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 50090-7315). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907315)

FDA Label Image

Chemical Structure (Tadalafil 1)

FDA Label Image

Tadalafil-tablets-figure-1 (Tadalafil 2)

This text provides data on the difference in blood pressure measurements between Tadalafil and a Placebo in millimeters of mercury (mmHg) for standing systolic and diastolic BP, as well as supine systolic and diastolic BP over time in hours.*

FDA Label Image

Tadalafil-tablets-figure-2 (Tadalafil 3)

This is not a valid content.*

FDA Label Image

Tadalafil-tablets-figure-3 (Tadalafil 4)

FDA Label Image

Tadalafil-tablets-figure-4 (Tadalafil 5)

This is a chart showing the plasma concentration of Tadalafil at different time points after administration of different doses. The chart includes data for a single 20mg dose, a single 5mg dose, and a once-daily 5mg dose following 5 consecutive days of administration. The x-axis represents time in hours and the y-axis shows the Tadalafil concentration in micrograms per liter (ug/L).*

FDA Label Image

Table 5 (Tadalafil 6)

FDA Label Image

Table 6 (Tadalafil 7)

FDA Label Image

Tadalafil-tablets-figure-7 (Tadalafil 8)

FDA Label Image

Image 8 (Tadalafil 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.